Anixa Biosciences Appoints UPenn's Dr. Carmen Guerra to Cancer Business Advisory Board
Anixa Biosciences appointed Dr. Carmen Guerra of the University of Pennsylvania's Perelman School of Medicine to its Cancer Business Advisory Board. Guerra is the Ruth C. and Raymond G.
Key figures
- Ovarian cancer cart stage
- Phase 1 clinical trial ongoing
- Breast cancer vaccine stage
- advancing to Phase 2 clinical trial
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.